The pharyngeal arches give rise to multiple organs critical for diverse processes, including the thymus, thyroid and parathyroids. Several molecular regulators of thymus and thyroid organogenesis are strikingly conserved between mammals and zebrafish. However, land animals have parathyroids whereas fish have gills. The murine transcription factor Glial cells missing 2 (Gcm2) is expressed specifically in the parathyroid primordium in the endodermal epithelium of the third pharyngeal pouch, and in both mice and humans is required for normal development of parathyroid glands. The molecular regulation of fish gill organogenesis remains to be described. We report the expression of gcm2 in the zebrafish pharyngeal epithelium and a requirement for Hox group 3 paralogs for gcm2 expression. Strikingly, zebrafish gcm2 is expressed in the ectodermal portion of the pharyngeal epithelium and is required for the development of the gill filament buds, precursors of fish-specific gill filaments. This study identifies yet another role for a GCM gene in embryonic development and indicates a role for gcm2 during the evolution of divergent pharyngeal morphologies. D
Introduction
Comparison of the embryology of pharyngeal organogenesis in land animals and fish reveals several striking similarities despite significant differences in the final anatomical outcome. The mammalian pharyngeal arches give rise to the thymus, thyroid and parathyroid glands. Fish also develop thyroid and thymus glands from their pharyngeal regions, but lack parathyroid glands and form gills. Whilst recent studies have shown that many key molecular regulators of thymus and thyroid organogenesis are functionally conserved between the zebrafish and mammals (Boehm et al., 2003; Elsalini et al., 2003; Rohr and Concha, 2000; Wendl et al., 2002) , the molecular regulation of gill organogenesis and its relationship, if any, to mammalian pharyngeal organogenesis, remains to be described.
In both mice and zebrafish, the thyroid develops from the ventral midline endodermal epithelium of the pharynx (Elsalini et al., 2003; Macchia, 2000; Rohr and Concha, 2000; Wendl et al., 2002) . The early thyroid primordium expresses hhex and nkx2.1 in both mice and zebrafish and furthermore, the loss of function phenotypes for these early thyroid determinants are similar, indicating significant conservation of both thyroid morphogenesis and its molecular control (Elsalini et al., 2003; Rohr and Concha, 2000) . The murine thymus develops from the thymic primordium in the endoderm of the third pharyngeal pouch. Prior to differentiation towards definitive thymic tissues, thymic primordium is marked by the transcription factor Foxn1 (the nude gene), which is expressed in the portion of the third pharyngeal arch primordium immediately ventral to and abutting the parathyroid primordium (Gordon et al., 2001) . Loss of Foxn1 leads to the ablation of the ablation of thymus in the classic nude mouse (Blackburn et al., 1996; Nehls et al., 1996) . In zebrafish, foxn1/whnb expression is also restricted to the pharyngeal epithelium (in the fifth pharyngeal [i.e., third branchial] arch), where its appearance precedes the expression of functional thymic markers such as rag1 and lck (Hansen and Zapata, 1998; Schorpp et al., 2002; Willett et al., 1997) .
Prior to organogenesis, the segmentation and patterning of the pharyngeal pouches requires the activity of multiple Hox genes in both mammals and in zebrafish. HoxA3 is critical for the establishment of the murine parathyroid/ thymic primordium in the third pharyngeal pouch, and HoxA3-deficient mice lack both a thymus and parathyroids Capecchi, 1995, 1998; Su et al., 2001) . In HoxA3-deficient mice, the loss of thymic marker Pax1 and parathyroid marker Gcm2 occurs from as early as E10.5 in an otherwise normal developmental context, and so is considered a likely cell autonomous requirement in pharyngeal endoderm, rather than due to neural crest defects (Manley and Capecchi, 1995; Su et al., 2001 ). Other Hox group 3 paralogs have also been implicated in pharyngeal organ development, with HoxA3 +/À, HoxB3 À/À, HoxD3À/À compound mutants displaying multiple pharyngeal defects (Manley and Capecchi, 1998) . Zebrafish hoxa3 and hoxb3 have almost identical expression patterns to their murine orthologs, but no role in pharyngeal organogenesis has yet been reported (Hadrys et al., 2004; Prince et al., 1998; Schilling et al., 2001) .
Given the degree of conservation in the molecular pathways required for early pharyngeal patterning and thyroid and thymus organogenesis, we were curious to understand the molecular processes responsible for one striking difference between the mammalian and piscine pharyngeal regions-the presence of parathyroid glands only in land animals, and of gills only in fish. The evolutionary origins of the parathyroid glands are coincident with the transition of marine vertebrates onto land, a process in which there was no longer a requirement for gills. The most basal existing taxa with parathyroid glands are amphibia, and all modern fish lack parathyroid glands (Hoar and Randall, 1969) .
In mice, the parathyroid glands develop as evaginations from the third pharyngeal pouch endoderm, and in humans, as evaginations from the third and fourth pharyngeal pouches. In mammals, the transcription factor Gcm2 (Glial cells missing 2) is expressed in the pharyngeal parathyroid primordium and later in the derived parathyroid glands (Gordon et al., 2001; Gunther et al., 2000; Kim et al., 1998) . Gcm2-deficient gene targeted mice lack parathyroids (Gunther et al., 2000) and Gcm2 has been exploited as a defining marker of parathyroid primordium in murine development (Correa et al., 2002; Gordon et al., 2001; Su et al., 2001; Xu et al., 2002) . Furthermore, a human family carrying a deletion in the GCM2 gene displays familial hypoparathyroidism (Ding et al., 2001) , characterising mammalian GCM2 as a conserved early regulator of parathyroid gland development from pharyngeal endoderm.
In this study, we have investigated the function of zebrafish gcm2. We show that gcm2 is expressed in the ectodermal epithelium of pharyngeal arches 3-6 (the branchial arches) and in the early gill filament evaginations as they bud from this region. Interestingly, expression of gcm2 is dependent on normal specification of the adjacent pharyngeal endoderm. We also show that zebrafish Hox group 3 paralogs are required for gcm2 expression, similar to murine HoxA3 and Gcm2 (Su et al., 2001) . When gcm2 function is blocked by morpholino-mediated knockdown of translation, the gill filaments fail to bud. Our studies suggest that although gills and parathyroids serve different physiological functions, and derive from different germ layers, their development employs conserved molecular regulators.
Materials and methods

Zebrafish
Wild-type and cloche mutant zebrafish stocks were held in the Ludwig Institute for Cancer Research Aquarium Facility using standard husbandry techniques. All procedures on live animals and embryos were approved by the Ludwig Institute for Cancer Research Animal Ethics Committee.
Collected embryos were incubated at 288C on a plate warmer; those for analysis at later timepoints were maintained in eggwater containing 0.003% 1-phenyl-2-thiourea (PTU) from 12 h post-fertilisation (hpf). Mutant embryos were sourced as follows: fixed casanova embryos a gift from Didier Stainier (University of California, San Francisco, CA), fixed foxi1 embryos a gift from Nancy Hopkins and Adam Amsterdam (Massachusetts Institute of Technology, Cambridge, MA), fixed swirl and maternal zygotic one eyed pinhead embryos a gift from Robert Ho (University of Chicago, Chicago, IL).
Cloning of gcm2
Degenerate oligonucleotide primers were designed employing the CODEHOP method (Rose et al., 1998) , primers were: 5V-GGATGGGCCATGAGAAACAC-NAAYAAYCA-3V and 5V-TCTGCTGCTTCTGTC-TGGCYTTRTCRCA-3V. The resultant 155-bp product was subcloned into pCR2.1 (Invitrogen) and the sequence used to design oligonucleotide primers for 5V and 3V RACE (rapid amplification of cDNA ends), primers were: 5V-GTCTCAG-CTGAAGTTTGGATCCGTCTGG-3V and 5V-TCTTG-TCTTGGTGTGGTGGTGTGCTCAC-3V. Products were cloned into pCR2.1 (Invitrogen) and sequenced.
A PolyA Tract mRNA purification system IV (Promega) was used to isolate high quality polyA mRNA for use as a RACE template. RACE was performed using the CLON-TECH SMARTk RACE cDNA Amplification Kit to the manufacturer's specifications.
The gcm2 cDNA was PCR amplified from RACE template (VENT DNA polymerase (New England Biolabs)) and cloned into pCS2+ (ATGgcm2) (Turner and Weintraub, 1994 ) (EcoRI, XhoI), primers were: 5V-GCGCGAATTCGC-CACCATGTCCAAATCCTCAGATCAGTTTGAC-3V and 5 V-GCGCCTCGAGTCAGTATTCCCCGCTGTCA-TATCTG-3V. The UTRgcm2 cDNA construct was created by subcloning a region including 5V UTR from the 5V RACE product (EcoRI, PvuII) into the gcm2 cDNA construct in pCS2+.
The phylogenetic tree ( Fig. 1a ) was generated as previously described (Lieschke et al., 2002) . The genomic Southern blot was performed using the cloned CODEHOP PCR product as a probe as previously described (Lieschke et al., 2002) . Stringency was defined by final washing in 0.5Â SSC, 1% SDS at 568C.
RT-PCR analysis
RT-PCR was performed as previously described (Lieschke et al., 2002) . Primer sequences were: gcm2 5V-GATC-CAAATCATGTCCAAATCCTC-3Vand 5V-AGCCTTCCCA-TCTACTCTCC-3V; h-actin 5V-TGGCATCACACCTTCTAC-3Vand 5V-AGACCATCACCAGAGTCC-3V.
Whole-mount in situ hybridisation
Whole mount in situ hybridisation analyses were performed as previously described (Lieschke et al., 2002; Oates et al., 1999) . Two gcm2 riboprobe templates were generated by subcloning the 5V RACE product (XhoI, EcoRI; Probe 1) and a 3V fragment cut out of the cloned cDNA (EcoRV, XhoI; Probe 2) into pBluescript (Stratagene). Riboprobes were synthesised by linearising and transcribing with: Probe 1 XhoI, T3 for antisense, EcoRI, T7 for sense and Probe 2 EcoRV, T3 for antisense. Sense controls produced no staining in initial in situ hybridisation experiments and so were not repeated routinely.
mRNA synthesis
The gcm2 mRNA was made by linearising template constructs with Not1 followed by synthesis of capped fulllength mRNA as previously described (Lieschke et al., 2002) . The full-length cDNAs for hoxa3 and hoxb3 (accession numbers: hoxa3 NM_131534, and hoxb3 AJ537509) were directly amplified from an 18 hpf cDNA library (kindly provided by Bruce Appel, Vanderbilt University, Nashville, TE) and cloned into pCS2+, hoxa3 as an XhoI-XbaI fragment and hoxb3 as an EcoRI-XbaI fragment. Primers used were: hoxa3 5V-CCGCTCGAGG-G A A A C G G C G A G AT G C A A A A G -3 V a n d 5 V-GCTCTAGAACTGCGCCACTATAAATGCGTC-3V; hoxb3 5V-GGAATTCAGCAACTCGATTTTTGGAAA-3V and 5V-GCTCTAGATGCCACTGTTACCCTGTAGC-3V. mRNA for in vitro translation (Fig. 7 ) was synthesised as previously described (Hunter and Prince, 2002) .
Morpholino oligonucleotides
Morpholino oligonucleotides (MOs) used were synthesised by Genetools, LLC. Microinjection was performed as previously described (Lieschke et al., 2002) .
Sequences for targeting gcm2 were (with start codon underlined): M01, 5V-CTGATCTGAGGATTTGGACAT-GATT-3V; M02, 5V-AGTTTCAAGGCAAAATTCAGC-TCGG-3V; M03, 5V-TGGACATGATTTGAGTCAACTC CGG-3V and M01 control with five mismatched base pairs (lower case), 5V-CTcATgTGAGGAaTTGGACtTGtTT-3V.
gcm2 morpholinos were injected in the concentration range 3.75-15 ng/embryo: 7.5 ng/embryo and 15 ng/embryo produced the typical gcm2 morphant phenotype described. A total morpholino concentration of 7.5 ng/embryo did not produce common non-specific defects (Nasevicius and Ekker, 2000) and was selected for these studies as a maximum dose deliverable to theoretically maximise the duration and efficiency of translational interference.
Morpholino sequences for targeting hoxa3 and hoxb3 were: Start codon targeting morpholinos; hoxa3MO, 5V-CAGTAGGTTGCCTTTTGCATCTCGC-3V and hoxb3MO, 5V-CGTAGTAGGTCGTTTTCTGCATTTC-3V hoxa3MO and hoxb3MO morpholinos were injected at a concentration of 4 ng/embryo (4 + 4 ng/embryo for combined morpholino injections) which failed to produce common non-specific defects. Hox group 3 start codon targeting morpholino knockdown data was also confirmed with independent hoxa3 and hoxb3 morpholino oligonucleotides targeted to the first donor splice site within each gene. The splice site directed morpholino sequences were: hoxa3MO
Sp , 5V-GGTTGATG-TAATCACCTGAAATGAT-3V and hoxb3 MO Sp , 5V-TTTGGCAAACACACCATTAGCTGAG-3V. hoxa3MO
Sp and hoxb3MO
Sp were injected at 4 ng/embryo (4 + 4 ng/ embryo for combined morpholino injections). The standard random sequence morpholino control used was: 5V-CCTCTTACCTCAGTTACAATTTATA-3V.
Inhibition of in vitro translation assays
In vitro translation of mRNA was performed using Promega's Rabbit Reticulolysate System according to manufacturer's instructions in the presence or absence of a MO (1:100 dilution final from a 20-mg/ml stock). Electrophoresis was performed using a 12% Tris-Glycine precast gel (Invitrogen), and transferred to a nylon membrane (Hybond N+, Amersham Pharmacia Biotech) by standard methods. The membrane was exposed overnight to a Phosphor screen (Molecular Dynamics Inc.) and processed in a Molecular Dynamics Phosphorimager system; single protein bands of the expected sizes were produced from each RNA. Relative protein amounts were quantified using the ImageQuant Program version 1.2 (Molecular Dynamics Inc.).
Staining of craniofacial cartilage and bone
Morphant embryos for Alcian blue staining were preselected for the typical morphological phenotype described at 4 and 5 dpf. Anesthetised larvae were fixed in 3.7% formaldehyde at room temperature for several hours to overnight, they were rinsed briefly in acid alcohol solution (70% ethanol, 1% concentrated HCl) and then transferred . b-actin control is shown below. gcm2 transcripts were first detected in 10 hpf cDNA, and throughout development to 72 hpf. Expression of gcm2 was also detected in cDNA from adult brain, testis and a crude skin and adipose tissue extract. The primers spanned introns and amplified larger fragments from gDNA. into a 0.1% Alcian blue solution in 80% ethanol/20% glacial acetic acid. After overnight staining, larvae were rinsed in ethanol, cleared in acid alcohol solution and imaged in 50% glycerol, 0.5% KOH. Calcein staining of early larval bones was performed as previously described (Du et al., 2001 ).
Microscopy and imaging
Embryos were imaged using an Olympus DP10 digital camera on either a Leica FL-111 dissecting microscope or a NIKON eclipse TE2000-E compound microscope. DIC microscopy was performed on a NIKON eclipse TE2000-E compound microscope. Calcein staining false colour images were created on a Leica FL-111 dissecting microscope with a Coolsnap HQ camera (Roper Scientific Photometrics) using RS image 1.7.3 software (Roper Scientific). To optimise clarity in the presentation of the panels, rostral is left and dorsal is up in all panels unless otherwise indicated, scale bars are provided only in the absence of standard anatomical landmarks; the inter-pharyngeal arch distance, indicated precisely in Figs. 2d and e, demonstrates the magnification.
Results
Cloning of gcm2
We cloned and examined gcm2 in zebrafish. A 2116 base pair (bp) zebrafish gcm cDNA was isolated (Accession number AY217729). The cDNA encoded a predicted 496 amino acid protein 45% identical to human GCM2, and 42% identical to mouse Gcm2 across the full length of the predicted protein, and within the DNA binding domain 82% and 80% identical to the human and murine GCM2, respectively. The most similar GCM1 protein was murine Gcm1 which was 36% identical (full-length) and 75% identical in the DNA binding domain, confirming phylogenetic analyses which indicated that the zebrafish gcm gene was a member of the GCM2 subfamily (Fig. 1a) . Databases contained partial sequences for gcm2 orthologues in two other teleosts, Takifugu rubripes and Tetraodon nigroviridis and two putative gcm1 orthologues in Xenopus laevis, although we found no gcm1 orthologues in zebrafish (approximately 95% of the genome sequenced) or any fish species represented in public databases (Figs. 1a, b) .
The genomic structure of the gene was strikingly similar to that of mammals, containing four introns at the start of the gene (Fig. 1c) . A genomic Southern blot, using a probe corresponding to the conserved DNA binding domain revealed single fragments from several restriction enzyme digestions of genomic DNA, indicating the presence of a single copy of the gcm2 gene in the zebrafish genome (Fig. 1d) .
Zebrafish gcm2 is expressed in the pharyngeal ectodermal epithelium and gill filament buds
We examined the expression of gcm2 during embryonic development using whole-mount in situ hybridisation and reverse transcriptase (RT) PCR (Fig. 2) . Like murine Gcm2, zebrafish gcm2 expression was detected in the pharyngeal epithelium, but extended over arches 3-6 (the branchial arches) and was localised in the external (lateral), ectodermal portion of the epithelium (Figs. 2a-e) . Pharyngeal expression was first detected at 32 hpf with expression , siblings (arrowhead in a) from a cross between known casanova heterozygotes, but staining was absent in casanova, cas À/À mutants (b). (c, d) foxi1 is required for the expression of gcm2. gcm2 transcripts were detected by in situ hybridisation at 72 hpf in wild type, foxi1 +/? siblings from a cross between known heterozygotes for foxi1 (arrowhead in c), but staining was severely reduced or absent in foxi1 À/À mutants (d).
initiating progressively in the developing branchial arches in a rostral to caudal sequence from 32 to 48 hpf. By 48 hpf, expression was observed in all four arches, where it persisted to at least day 5 (Figs. 2a-c) . gcm2 expression occurred in the gill filament buds as they evaginate from the pharyngeal ectoderm from 72 to 74 hpf, these distinctive structures (shown at 96 hpf-arrowhead Fig. 2c) give rise to the fish-specific gill filaments (Kimmel et al., 1995) . Additionally, from 10 hpf, gcm2 was expressed in a population of cells scattered over the yolk in the epidermis (Figs. 2f and g ). By 20 hpf, these cells were dispersed over the entire yolk, yolk extension and tail (Fig. 2g) . These cells were located in the immediately sub-epithelial compartment (Fig.  2h ) and were absent in swirl mutants but not in maternal zygotic one eyed pinhead, cloche or in casanova mutants (data not shown). Taken together, these observations suggest that this gcm2-expressing cell population comprises nonneural ectoderm-derived epidermal cells. By virtue of their dispersed location, these cells are unlikely to be involved in pharyngeal development and so are not described further in these studies. RT-PCR analysis confirmed expression of gcm2 from as early as 10 hpf and throughout embryogenesis and in the adult testis, brain and integument (a crude skin and adipose tissue extract) (Fig. 2i). gcm2 expression in the pharyngeal ectoderm requires the normal specification of the pharyngeal endoderm
We examined pharyngeal gcm2 expression in the endoderm mutants casanova and foxi1. casanova mutants Fig. 4 . Validation of gcm2 morpholino oligonucleotide activity. (a) Representation of reagents used in a two-injection rescue experiment. Two pCS2+-based constructs were built to enable synthesis of two different gcm2 capped mRNA transcripts. The ATGgcm2 mRNA contained the full gcm2 coding sequence but did not include the full binding sites for any of the morpholino oligonucleotides used. The UTRgcm2 mRNA contained 5VUTR and the full gcm2 coding sequence and the full binding sites for the morpholino oligonucleotides MO1, MO2 and MO3. UTR is represented in red, coding sequence in blue. (b-k) Rescue of the gcm2 overexpression phenotype occurred only in the presence of complete morpholino oligonucleotide binding sites. In this experiment, test mRNA (50 or 100 ng/AL) was injected at the 1-2 cell stage and morpholinos injected via a second separate needle at the 2-4 cell stage. mRNA encoding enhanced green fluorescent protein (EGFP) was co-injected (15 ng/AL) with test mRNA as a tracer of mRNA delivery and as a further specificity control. Injections of ATGgcm2 and UTRgcm2 mRNA resulted in a highly reproducible early axis-patterning defect (c, d), which was not rescued by a separate, second injection of the mis-matched control morpholino (misMO) (e) and was not observed in uninjected embryos (b). A second separate injection of MO1, MO2 or MO3 rescued the overexpression phenotype in UTRgcm2 mRNA injected embryos (f-h) but not in ATGgcm2 mRNA injected embryos (i-k), nor did any morpholino affect EGFP expression. Combined scores from two separate experiments are shown in the bottom right of each panel in three categories of phenotype severity: grossly elongated embryos/ mildly dysmorphic embryos/phenotypically normal embryos. Merged false color images are shown, with green indicating the presence of EGFP. lack endoderm (Alexander and Stainier, 1999; Aoki et al., 2002; Kikuchi et al., 2001 ) and we examined the progeny of known heterozygotes for gcm2 expression. casanova mutants lacked pharyngeal expression of gcm2 at 48 hpf (Figs. 3a and b) . Furthermore, in phenotypically identifiable casanova mutants at 38 hpf (during the initiation of gcm2 expression), gcm2 expression was absent (n = 7 mutants amongst 29 siblings from a cas +/À Â cas +/À cross) indicating that endoderm was required for the initiation of gcm2 expression and not simply for its maintenance.
We also examined gcm2 expression in foxi1 mutants, which lack normal patterning of pharyngeal endoderm (Nissen et al., 2003; Solomon et al., 2003) . foxi1 mutants lacked pharyngeal expression of gcm2 at 72 hpf (Figs. 3c  and d) . Expression was also absent in foxi1 mutants at 48 hpf (data not shown). Taken together, these data show that initiation of gcm2 expression in the external ectodermal compartment requires normal specification of the pharyngeal endoderm.
gcm2 is required for gill filament budding
We used morpholino (MO) oligonucleotide knock-down of transcript translation (Nasevicius and Ekker, 2000) to examine gcm2 function and uncover a requirement for gcm2 in gill filament budding and craniofacial development. To first validate MO efficacy and specificity, we took advantage of the overexpression phenotype for gcm2 (Fig. 4) . gcm2 overexpression by mRNA injection led to a dose-dependent induction of axis patterning defects which was associated with the ectopic induction of chordin from as early as 30% epiboly (data not shown). The early embryonic lethality of this phenotype precluded classic rescue of morphant phenotype experiments. Therefore, we injected gcm2 mRNA, with and without the full MO binding sites, in the presence and absence of MOs targeted to gcm2 transcripts. MOs specifically inhibited the overexpression phenotype, but only when the full MO binding sites were present in the injected gcm2 mRNA (Figs. 4f-k) . Furthermore, gcm2 MOs failed to inhibit the translation of EGFP from mRNA, which was co-injected with the gcm2 mRNA. In order to prevent binding of gcm2 to MOs in vitro, these rescue experiments were performed by injecting firstly the mRNA, followed by a separate second injection of MO. Hence, gcm2 MOs were capable of specifically targeting gcm2 mRNA in vivo, but only in the presence of intact MO binding sites. Furthermore, the temporally regulated expression of a series of well-characterised genes assayed from early somitogenesis to 3 dpf (including: gata1, spi1, l-plastin, c-myb, myeloperoxidase, apolipoproteinE, runx1, intestinal fatty acid binding protein, prox1, pdx1, insulin, crestin, dlx2) was normal in MO injected embryos, indicating the specificity of the MO phenotype (data not shown).
MO-injected embryos (morphants) displayed a characteristic combination of phenotypic defects from 3 days post-fertilisation (dpf), comprising enlarged yolks, a hypoplastic gastrointestinal tract, under-developed otoliths and decreased protrusion of the jaw, prominent at 5 dpf (Figs. 5a-d) . Alcian blue-stained morphants displayed specific abnormalities of variable severity in craniofacial cartilage development (Figs. 5e-j) . In uninjected and standard random-sequence MO control-injected embryos, early calcification of the cleithrum was invariably detected by calcein staining (Du et al., 2001 ) from 4 dpf, however, this staining was absent in 4 dpf gcm2 morphants (Figs.  5k and l) . Given the ectodermally restricted expression of gcm2, these skeletal phenotypes are likely non-cell autonomous. To identify cell autonomous requirements for gcm2 in pharyngeal development, we analysed gill filament buds in wild-type and gcm2 morphant embryos. DIC microscopy of uninjected 98 hpf control embryos invariably revealed distinctive budding, whilst in gcm2 morphants, gill filament budding was severely reduced or absent (Figs. 5q, t) .
We exploited the phenomenon of MO oligonucleotidemediated stabilisation of target mRNA in vivo to examine gill filament budding in gcm2 morphants using gcm2 as a marker. At 80 hpf, distinctive gill filament budding was observed in wild-type embryos (Fig. 5r ) whereas, morphant embryos had either no budding or severely reduced budding at this developmental stage (Fig.  5u) . At 98 hpf, whilst uninjected or mis-matched MO injected controls all showed expression in gill filament buds (Fig. 5s) , morphants showed no budding or severely reduced budding (Fig. 5v) . Furthermore, at 76 hpf, the expression of rag1 in the developing thymus, adjacent to the gill filament buds, was normal (Figs. 5m, n) , as was the early development of the thyroid, marked by nkx2.1 at 44 hpf (Figs. 5o, p) indicating the specificity of these phenotypes.
Hox group 3 paralogs are broadly expressed throughout the developing pharyngeal pouches preceding gcm2 expression
To better understand the role played by gcm2 during evolutionary changes in pharyngeal morphology, we investigated the control of its expression in the developing zebrafish pharyngeal arches. Murine HoxA3 is expressed in the pharyngeal endoderm and HoxB3 in the pharyngeal ectoderm (Hunt et al., 1991a,b; Manley and Capecchi, 1995) . HoxA3 likely acts cell autonomously upstream of Gcm2 in the mouse (Manley and Capecchi, 1995; Su et al., 2001) . In zebrafish, hoxa3 and hoxb3 expression in the pharyngeal region occurs at times that are both earlier than and concomitant with those we describe for gcm2 expression (Hadrys et al., 2004; Prince et al., 1998; Schilling et al., 2001 ), but it was unclear if their expression domains include the ectoderm or endoderm. Hence, to determine if pharyngeal hoxa3 and hoxb3 expression was restricted to the neural crest, or if their expression is found in ectodermal cells where they may act cell-autonomously upstream of gcm2, we compared the expression patterns of hoxa3 and hoxb3 with the expression of crestin (marking the neural crest) and dlx2 (marking the neural crest derived mesenchyme) (Fig. 6) .
Both hoxa3 and hoxb3 were expressed broadly throughout the pharyngeal region at 24 hpf and were not restricted to the neural crest or neural crest derived mesenchyme, indicating that their expression is located in an appropriate region to potentially exert a direct influence over gcm2 expression (Fig. 6) . To determine if hoxa3 and hoxb3 expression in the pharyngeal ectoderm coincided with the initiation of gcm2 expression, we sectioned embryos at 38 hpf, which is during the time of initiation of gcm2 expression. At 38 hpf, gcm2 expression was typically observed in the ectoderm of the two rostral-most branchial arches (Fig. 6i, inset) . At the same time, broad expression of hoxa3 and hoxb3 in the developing caudal branchial arches included expression in the ectoderm (Figs. 6i, j) . At this timepoint, in the more mature rostral arches, hoxa3 and hoxb3 expression was enriched in the mesenchyme. Later in development, at 48 hpf, sectional analysis revealed that hoxa3 and hoxb3 expression was predominantly restricted to the mesenchyme (data not shown). Hence, both Hox genes were expressed in the ectoderm during the period of initiation of gcm2 expression but became more restricted to mesenchyme thereafter.
Hox group 3 paralogs are required for gcm2 expression
To determine whether gcm2 expression was dependent on the function of hoxa3 and hoxb3, we analysed gcm2 expression in morphants for hoxa3, hoxb3 and hoxa3/hoxb3 together at 50-52 hpf and 76 hpf. Activity of the Hox group 3 MOs which were targeted to the start codon (hoxa3MO and hoxb3MO) was first validated using an inhibition of in vitro translation assay (Fig. 7i) . The specificity of hoxa3MO and hoxb3MO effects was further verified by replication of observations with splice donor site targeting MOs (hoxa3-MO Sp and hoxb3MO Sp ) (Table 1) . In contrast to HoxA3-deficient mice, hoxa3 morphants were wild type in appearance and displayed normal gcm2 expression (Fig. 7b, Table 1) . However, at 50-52 hpf, knock-down of hoxb3 led to a marked reduction in gcm2 expression, with expression most commonly observed in the ectoderm of only two branchial arches (Fig. 7c, Table  1 ), whereas in wild-type controls, gcm2 was expressed in all four branchial arches. gcm2 expression in hoxb3 morphants at 76 hpf remained reduced, but to a lesser extent (Table 1) ; this increase in gcm2 expression likely reflected dilution or degradation of the hoxb3MO reagent by these later stages of development.
In compound hoxa3/hoxb3 morphants, the loss of gcm2 expression was enhanced. At 50-52 hpf, gcm2 expression was generally reduced to low level expression in one arch (Fig. 7d, Table 1 ) and although gcm2 expression had again recovered partially by 76 hpf, it remained reduced compared to hoxb3 morphants (Table 1 ). The loss of gcm2 expression was specific to the knockdown of Hox group 3 paralog function and not due to general developmental delay because morphants showed no obvious specific morphological defects and expressed rag1 normally at 78 hpf by single riboprobe in situ hybridisation (data not shown). Furthermore, when analysed by double in situ hybridisation for both gcm2 and rag1, hoxa3/hoxb3 morphants that displayed decreased gcm2 expression and decreased gill filament budding at 78 hpf retained normal expression of rag1 in the developing thymus (Figs. 7e and f) .
To determine whether Hox group 3 paralogs were required for the initiation of gcm2 expression or were simply required for its maintenance, we looked at gcm2 expression in hoxa3/hoxb3 morphants at 38 hpf, during the time of initiation of gcm2 expression. In both hoxa3MO/hoxb3MO and hoxa3MO
Sp /hoxb3MO
Sp double morphants, gcm2 expression was vastly reduced or absent (n = 44/47 hoxa3MO/hoxb3MO double morphants and n = 42/48 hoxa3MO Sp /hoxb3MO Sp double morphants, expression was normal in n = 62/62 random sequence control MO-injected embryos).
To further investigate the compensation of hoxa3 in the absence of hoxb3, we examined hoxa3 expression in hoxb3 morphants. We found that hoxa3 staining intensity was consistently increased in hoxb3 morphants (Figs. 7g and h) , showing that hoxa3 is up-regulated in the absence of hoxb3 function.
Discussion
Gill filament budding employs similar molecular regulators to parathyroid gland development
We have shown that unlike murine Gcm2, which is expressed in third pharyngeal pouch endoderm and required for parathyroid gland development (Gunther et al., 2000) , zebrafish gcm2 is expressed in the ectodermal epithelium of the branchial arches and is required for gill filament bud d) . The morphant phenotype was generated with an ATG targeted morpholino, MO1 (approximately 7.5 ng/embryo), at 98% frequency (n = 167). The phenotype was reproduced with an injection of two morpholino oligonucleotides combined (78% frequency, n = 84): a 5Vuntranslated region targeted morpholino, MO2; and a second ATG targeted morpholino, MO3 (approximately 3.75 + 3.75 ng/embryo), which partially overlaps with the MO1 sequence. d is enlarged image of boxed section in c. (e-j) Morphants display specific defects in craniofacial cartilage development at 4 and 5 dpf. Four dpf uninjected and random-sequence morpholino-injected control embryos (n = 12) (e) stained with Alcian blue displayed wild-type craniofacial cartilages for this timepoint. gcm2 morphants (n = 67) displayed either bmildQ defects in craniofacial cartilage development (29% of embryos scored) (f) or bsevereQ defects in craniofacial development (18% of embryos scored) (g). The mis-matched control morpholino failed to produce the phenotypes described (n = 27). Five dpf uninjected and random-sequence morpholino (n = 21) control embryos (h) stained with Alcian blue displayed wild-type craniofacial cartilages for this timepoint. gcm2 morphants (n = 79) displayed either bmildQ defects in craniofacial cartilage development (31% of embryos scored) (i) or bsevereQ defects in craniofacial development (10% of embryos scored) (j). The mis-matched control morpholino failed to produce the phenotypes described (n = 35). (k, l) Reduced calcein staining in morphants. Calcein staining of the cleithrum at 4 dpf was invariable in uninjected controls (arrowhead in k) and in mis-matched morpholino injected controls (n = 43), but was absent in MO2 + MO3 injected morphants at 4 dpf (80% of embryos scored, n = 45) (l). (m, n) Normal rag1 expression in morphants. In situ hybridisation for rag1 at 76 hpf stained the developing thymus in uninjected controls (arrowhead in m) and in morphants (arrowhead in n). (o, p) Normal nkx2.1 expression in morphants. In situ hybridisation for nkx2.1 stained the developing thyroid at 44 hpf in uninjected controls (arrowhead in o) and in morphants (arrowhead in p). (q, t) Gill filament buds were absent or vastly reduced in morphants at 98 hpf. Gill filament buds were observed under DIC microscopy in uninjected controls at 98 hpf (n = 29) (q) but were absent or vastly reduced in morphants (n = 20/26 embryos for MO1 injected and n = 28/31 for MO2 + MO3 injected) (t). Buds are indicated by arrowheads, arches 3-6 are labelled, h = heart. (r, s, u, v) Gill filament buds expressing gcm2 were absent in gcm2 morphants. In situ hybridisation for gcm2 transcripts at 80 hpf in uninjected controls (r) showed the budding of gill filament buds as ruffled staining of arches 3-6 (arrowhead) (n = 20) which was absent or vastly reduced in morphants (n = 12/14 for MO1 injected, n = 33/40 for MO2 + MO3 injected) (u). In situ hybridisation for gcm2 transcripts at 98 hpf in uninjected controls (s) also showed the budding of gill filament buds (arrowhead) (n = 30) which was absent or vastly reduced in morphants (n = 16/26 MO1 injected, n = 48/50 MO2 + MO3 injected) (v). Five mismatched control injected embryos were indistinguishable from uninjected control embryos at 98 hpf (n = 22).
development. gcm2 is also required non-cell autonomously for normal pharyngeal cartilage development. As gcm2 functions as a transcription factor, this requirement implies that inductive or permissive signalling from the ectoderm may be required in the development of other pharyngeal tissues. Interestingly, the specification of the adjacent pharyngeal endoderm is necessary for the normal initiation of gcm2 expression in pharyngeal ectoderm, indicating a requirement for inductive signalling from the endoderm for expression of this particular ectodermal transcription factor.
Somewhat unexpectedly, our observations present molecular evidence for a developmental relationship between mammalian parathyroids and piscine gill filaments. We show that gcm2 is expressed in zebrafish gill filament buds and is essential for their budding morphogenesis. A requirement for hoxa3 and hoxb3 for the initiation of gcm2 expression parallels the relationship between murine HoxA3 and Gcm2 (Manley and Capecchi, 1995; Su et al., 2001) . Interestingly, mutations in another gene expressed in the parathyroid glands, Gata3, also led to familial hypoparathyroidism in humans identifying another important regulator of parathyroid development in mammals (Debacker et al., 1999; George et al., 1994; Nesbit et al., 2004) . Like gcm2, the zebrafish gata3 ortholog is also expressed throughout the gill filament buds (Trede et al., 2001) . Hence, two known molecular regulators of mammalian parathyroid development have restricted expression in the zebrafish gill filament buds.
Despite this striking molecular similarity, the anatomy of gill filament morphogenesis is divergent from the anatomy of parathyroid development. The gills are derived from pharyngeal arches 3-6 and bud from the external ectodermal epithelium (Goodrich, 1930; Hyman, 1942) , whilst the parathyroids are derived from the third pharyngeal pouch endoderm in mice (pouches 3 and 4 in humans) at the immediate endoderm-ectoderm epithelial junction (Gordon et al., 2001 ).
Although we have observed significant similarity between the molecular determination of gill filaments and Fig. 7 . hoxb3, and in its absence hoxa3, are required for normal gcm2 expression. (a-d) Hox group 3 paralogs are required for normal gcm2 expression. Expression of gcm2 in uninjected control embryos at 52 hpf was detected by in situ hybridisation in arches 3-6 (a) and was unchanged in hoxa3 morpholinoinjected embryos (b), but was reduced in hoxb3 morpholino-injected embryos (c) and further reduced in hoxa3 + hoxb3 morpholino-injected embryos (d). (e, f) Expression of gcm2 was reduced in hoxa3MO/hoxb3MO morphants in the presence of normal rag1 expression. Expression of gcm2 in distinctive gill filament buds and rag1 in the thymus was detected at 78 hpf in uninjected control embryos (n = 31/35 embryos) (arrowhead in e indicates rag1 expression, lower panel is an enlarged image of boxed section in e, arrowheads in lower panel indicate gill filament buds). Expression of rag1 was also detected in hoxa3MO/ hoxb3MO morphants even in the presence of reduced gcm2 expression and reduced gill filament budding (n = 41/71 with reduced gcm2, reduced budding, rag1 positive; n = 14/71 wild type; n = 16/71 with reduced gcm2, reduced budding, rag1 negative) indicating the specificity of the reduced gcm2 phenotype (arrowhead in f indicates rag1 expression, lower panel is an enlarged image of boxed section in f, arrowheads in lower panel indicate gill filament buds). (g, h) Expression of hoxa3 was increased in the absence of hoxb3. Normal expression of hoxa3 was detected by in situ hybridisation in concurrently stained 50 hpf uninjected control embryos (g) and increased intensity of staining was detected in 50 hpf hoxb3MO-injected embryos (n = 34/43) (h). To control against variation in staining, we performed in situ hybridisation on mixed control and MO injected batches, ensuring consistent staining between MO and control injected embryos. We used tail-clipping of experimental groups to provide simple identification of control or MO injected embryos post in situ hybridisation. The identical experiment using random sequence control MO embryos generated n = 33/46 hoxb3MO-injected embryos displaying more intense staining than observed in n = 48 random sequence control MO injected embryos, which was reproduced with hoxB3MO
Sp (data not shown). (i) Specific activity of hoxa3MO and hoxb3MO, start codon targeted morpholinos assessed by inhibition of in vitro translation assay. hoxb1a mRNA was translated efficiently in the presence of hoxa3 and hoxb3MOs (lanes 1 and 5) and in the absence of MOs (lane 4). Translation efficiency of hoxb3 mRNA in the presence of hoxb3MO (lane 2) represents b15% the translation product seen with hoxb3 mRNA only (lane 3). Translation efficiency of hoxa3 mRNA in the presence of hoxa3MO (lane 6) represents b5% the translation product seen with hoxa3 mRNA only (lane 7). parathyroids, we do not suggest that gill filaments play the physiological role of parathyroid glands. Furthermore, we were unable to detect expression of parathyroid hormone in any pharyngeal-derived organs in zebrafish embryos and early larvae (BH, GL, paper in preparation).
Upstream roles for Hox group 3 paralogs
In mice, it is likely that HoxA3 regulates Gcm2 directly (Manley and Capecchi, 1995) , although direct regulation remains to be shown at the molecular level. Murine HoxB3 is unlikely to regulate Gcm2 as it is not expressed in the pharyngeal endoderm, but is enriched in the surface ectoderm (Hunt et al., 1991a,b; Manley and Capecchi, 1995) . In zebrafish, hoxa3 and hoxb3 are expressed throughout the pharyngeal region at 24 hpf, preceding gcm2 expression, and are more broadly expressed than markers of neural crest and neural crest-derived mesenchyme (Fig. 6) . Sectional analysis at these timepoints, and also at 38 hpf (during the initiation of gcm2 expression) revealed broad expression of hoxa3 and hoxb3 in the developing branchial arches (Fig. 6 ) and included expression in the ectoderm during gcm2 initiation. Hence, Hox group 3 paralogs may act cell autonomously in the ectoderm to directly regulate gcm2 expression.
Injection of hoxb3 MO but not hoxa3 MO led to a loss of pharyngeal expression of gcm2 which was further reduced when both MOs were injected together. Hence, in zebrafish, it is hoxb3 that is most critical for gcm2 expression; only in the absence of hoxb3 is a role for hoxa3 uncovered, a strikingly different scenario to that observed in the mouse. At this point, it is unclear whether this requirement constitutes direct transcriptional control, although the timing of expression of Hox group 3 paralogs and gcm2 in the ectoderm and the failure of initiation of very early gcm2 expression in Hox group 3 morphants suggest that this is possible.
The altered expression of gcm2 we observe may also be due to an altered identity of the branchial arches in the absence of Hox group 3 paralogs. The loss of Hox group 3 paralogs in the branchial arches may lead to a homeotic transformation with loss of segmental identity. It is possible that Hox group 2, 4 or 5 paralogs may exert their influence in the absence of hoxa3 and hoxb3. However, this notion is not supported by a previous detailed analysis of arch identity using the start codon targeting MO reagents reported here, which failed to reveal any such transformations of identity (Hunter et al., unpublished) .
Evolutionary implications
The expanded expression of gcm2 in zebrafish, relative to mammals, leads us to speculate that the ancestral state of gcm2 expression may have resembled the domain seen in zebrafish. Although gcm2 expression has not been characterised in a third modern vertebrate taxon, previous studies of the fossil record have supplied a third point of evidence. In the Devonian period, the most ancient known tetrapods Acanthostega and Ichthyostega bore deeply grooved gill bars consistent with fish-like breathing and the presence of gill filaments (Clack et al., 2003; Coates and Clack, 1991 ). As we demonstrate that gill filament formation requires gcm2 activity, and hence may be considered a phenotypic proxy for gcm2 expression, fish-like breathing in these ancient tetrapods implies an expanded role for gcm2 in these animals in comparison with modern tetrapods.
We speculate that gcm2 was likely broadly expressed in the gill arches, but that its expression was rapidly restricted during the transition from marine to terrestrial vertebrates and appeared for the first time in pharyngeal endoderm, in the parathyroid primordia. Consistent with this hypothesis, the number of parathyroid glands (and presumably gcm2-expressing primordia) varies remarkably throughout the evolution of terrestrial vertebrates, with mice having one pair of parathyroids, humans two pairs (derived from the dorsal region of the arches in mammals) and some reptiles having three pairs (derived from the ventral region of the arches) (Hoar and Randall, 1969; Hyman, 1942) . Testing of this hypothesis requires further analysis of gcm2 expression in evolutionarily divergent extant vertebrates such as sharks, skates and lungfish, which may help to delineate how these organ primordia changed throughout evolution. a Scoring of severity was according to the following categories: normal = gcm2 expression was present in all (4/4) branchial arches and normal in extent. 1+ = gcm2 expression was present in all (4/4) branchial arches but reduced in extent. 2+ = gcm2 expression was present in 3/4 branchial arches. 3+ = gcm2 expression was present in 2/4 branchial arches. 4+ = gcm2 expression was present in 1/4 branchial arches. 5+ = gcm2 expression was absent in all branchial arches.
Addendum. While this manuscript was under review, Hanaoka et al., (Mechanisms of Development (2004) 121 (10) 1235-47) reported that gcmb (gcm2) was required for pharyngeal cartilage development, corroborating our data describing the non-cell autonomous role of gcm2. In the same manuscript, the injection of a morpholino targeting fgf3 led to a loss of gcm2 expression in the pharyngeal ectoderm, suggesting that fgf3 is likely the signal from the endoderm required for gcm2 expression in the pharyngeal ectoderm, as hypothesised in this manuscript.
